Preparation, characterization and in vitro release of β-galactosidase loaded polyelectrolyte nanoparticles

Int J Biol Macromol. 2018 Aug:115:1-9. doi: 10.1016/j.ijbiomac.2018.04.030. Epub 2018 Apr 10.

Abstract

Improving encapsulation efficacy (EE) and bioavailability of β-galactosidase (β-gal) is always a challenge due to its fragility. In this work, β-gal loaded β-chitosan (CS) nanoparticles (NPs) were successfully prepared based on ionic gelation technique and electrostatic attraction for improving its EE and in vitro releasing capacity. The particle size of β-gal loaded low and high molecular weight (LMW and HMW) β-CS NPs reached 584.37 and 652.46nm, with Zeta-potential (ZP) of 26.37 and 16.46mV under the optimal conditions, respectively. In vitro release study conducted at pH4.5 and 7.4 showed that β-gal loaded LMW and HMW β-CS NPs with EE of 68.32 and 58.64% sustained the release of the β-gal over 12h. The β-gal incorporated into β-CS NPs was confirmed with the results of physicochemical and structural properties of β-gal loaded β-CS NPs, and prepared NPs had hardly any cytotoxicity in the range of 0.1-1.0mg/mL. The results indicated that β-gal loaded β-CS NPs could serve as non-toxic delivery carriers for the treatment of lactose intolerance.

Keywords: Encapsulation efficacy; In vitro release; Nanoparticles; β-chitosan; β-galactosidase.

MeSH terms

  • Cell Line
  • Cell Survival / drug effects
  • Drug Carriers / chemistry*
  • Drug Carriers / toxicity
  • Drug Liberation*
  • Endothelial Cells / cytology
  • Endothelial Cells / drug effects
  • Molecular Weight
  • Nanoparticles / chemistry*
  • Particle Size
  • Polyelectrolytes / chemistry*
  • Polyelectrolytes / toxicity
  • beta-Galactosidase / chemistry*

Substances

  • Drug Carriers
  • Polyelectrolytes
  • beta-Galactosidase